Department of Gastroenterology and Gastrointestinal Oncology, University Medical Center Goettingen, 37075 Goettingen, Germany.
Int J Mol Sci. 2018 Oct 10;19(10):3104. doi: 10.3390/ijms19103104.
Inflammatory liver diseases in the absence of pathogens such as intoxication by xenobiotics, cholestatic liver injury, hepatic ischemia-reperfusion injury (I/R), non-alcoholic steatohepatitis (NASH), or alcoholic liver disease (ALD) remain threatening conditions demanding specific therapeutic options. Caused by various different noxae, all these conditions have been recognized to be triggered by danger- or death-associated molecular patterns (DAMPs), discompartmentalized self-structures released by dying cells. These endogenous, ectopic molecules comprise proteins, nucleic acids, adenosine triphosphate (ATP), or mitochondrial compounds, among others. This review resumes the respective modes of their release-passively by necrotic hepatocytes or actively by viable or apoptotic parenchymal cells-and their particular roles in sterile liver pathology. It addresses their sensors and the initial inflammatory responses they provoke. It further addresses a resulting second wave of parenchymal death that might be of different mode, boosting the release of additional, second-line DAMPs. Thus, triggering a more complex and pronounced response. Initial and secondary inflammatory responses comprise the activation of Kupffer cells (KCs), the attraction and activation of monocytes and neutrophil granulocytes, and the induction of type I interferons (IFNs) and their effectors. A thorough understanding of pathophysiology is a prerequisite for identifying rational therapeutic targets.
在不存在病原体的情况下,如外源性毒物中毒、胆汁淤积性肝损伤、肝缺血再灌注损伤(I/R)、非酒精性脂肪性肝炎(NASH)或酒精性肝病(ALD)等炎症性肝病仍然是威胁生命的疾病,需要特定的治疗方法。所有这些疾病都是由各种不同的毒物引起的,它们都被认为是由危险或死亡相关分子模式(DAMPs)触发的,这些模式是由死亡细胞释放的非局部自身结构。这些内源性异位分子包括蛋白质、核酸、三磷酸腺苷(ATP)或线粒体化合物等。这篇综述总结了它们的释放模式——坏死肝细胞被动释放或存活或凋亡实质细胞主动释放——以及它们在无菌性肝病理中的特定作用。它涉及到它们的传感器以及它们引发的初始炎症反应。它进一步涉及到可能是不同模式的第二波实质细胞死亡,这会促进额外的二线 DAMPs 的释放。从而引发更复杂和更明显的反应。初始和继发炎症反应包括枯否细胞(KCs)的激活、单核细胞和中性粒细胞的趋化和激活,以及 I 型干扰素(IFN)及其效应物的诱导。深入了解病理生理学是确定合理治疗靶点的前提。